Literature DB >> 19917815

Diagnosis and new treatments in genetic neuropathies.

M M Reilly1, M E Shy.   

Abstract

The genetic neuropathies are a clinically and genetically heterogeneous group of diseases of which the most common types are Charcot-Marie-Tooth disease (CMT), the hereditary sensory and autonomic neuropathies and the distal hereditary motor neuropathies. More than 30 causative genes have been described, making an accurate genetic diagnosis increasingly possible. Although no specific therapies are yet available, research into their pathogenesis has revolutionised our understanding of the peripheral nervous system and allowed the development of rational approaches to therapy. The first therapeutic trials in CMT are currently underway. This review will suggest an approach to the diagnosis of these disorders and provide an update on new therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19917815     DOI: 10.1136/jnnp.2008.158295

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

Review 1.  Advances in the laboratory evaluation of peripheral neuropathies.

Authors:  Mengjing Chloe Huan; Mark Bromberg
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  What is this thing called pain?

Authors:  Clifford J Woolf
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 3.  Inherited neuropathies.

Authors:  Jun Li
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

Review 4.  Inherited neuropathies and deafness caused by a PMP22 point mutation: a case report and a review of the literature.

Authors:  Marco Luigetti; Marcella Zollino; Guido Conti; Angela Romano; Mario Sabatelli
Journal:  Neurol Sci       Date:  2012-12-24       Impact factor: 3.307

5.  Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.

Authors:  Zhiliang Yu; Xiaohua Wu; Huijun Xie; Ying Han; Yangtai Guan; Yong Qin; Huimin Zheng; Jianming Jiang; Zhenmin Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in MYH14.

Authors:  Byung-Ok Choi; Sung Hee Kang; Young Se Hyun; Sumaria Kanwal; Sun Wha Park; Heasoo Koo; Sang-Beom Kim; Young-Chul Choi; Jeong Hyun Yoo; Jong-Won Kim; Kee Duk Park; Kyoung-Gyu Choi; Song Ja Kim; Stephan Züchner; Ki Wha Chung
Journal:  Hum Mutat       Date:  2011-04-07       Impact factor: 4.878

7.  Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease.

Authors:  Giorgia Bergamin; Francesca Boaretto; Chiara Briani; Elena Pegoraro; Mario Cacciavillani; Andrea Martinuzzi; Maria Muglia; Andrea Vettori; Giovanni Vazza; Maria Luisa Mostacciuolo
Journal:  Neuromolecular Med       Date:  2014-05-13       Impact factor: 3.843

8.  Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Authors:  Cristina Scapin; Cinzia Ferri; Emanuela Pettinato; Desiree Zambroni; Francesca Bianchi; Ubaldo Del Carro; Sophie Belin; Donatella Caruso; Nico Mitro; Marta Pellegatta; Carla Taveggia; Markus H Schwab; Klaus-Armin Nave; M Laura Feltri; Lawrence Wrabetz; Maurizio D'Antonio
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

9.  Anterior tibialis CMAP amplitude correlations with impairment in CMT1A.

Authors:  Kelsey Komyathy; Stephanie Neal; Shawna Feely; Lindsey J Miller; Richard A Lewis; George Trigge; Carly E Siskind; Michael E Shy; Sindhu Ramchandren
Journal:  Muscle Nerve       Date:  2013-03-03       Impact factor: 3.217

10.  Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

Authors:  Nicholas E Johnson; Chad R Heatwole; Nuran Dilek; Janet Sowden; Callyn A Kirk; Denise Shereff; Michael E Shy; David N Herrmann
Journal:  Neuromuscul Disord       Date:  2014-06-27       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.